ATLASATLAS fair value
ATLAS has no fair value for this stock today.
Profound Medical (PROF)
Profound Medical stock price today, ATLAS forecast and fair value
Healthcare · Medical Devices · NASDAQ
$5.63▲ +1.44%
Prices as of Oct 27, 2026 · USD
Chance of rising in 1 month
46%
that it ends higher than today in 21 sessions
0%coin flip 50%100%
This is just the summary. See everything on Profound Medical in ATLAS
ATLAS's own quantitative analysis, all in one place.
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
See everything included
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
On Profound Medical
- Simulation and expected rangeThousands of simulated scenarios: how far the price could rise or fall.
- Officers and shareholdersWho runs the company and which funds hold its shares.
- Customer and supplier mapWho it does business with, from its own filings.
- Valuation and financialsFair value step by step, quarterly accounts and upcoming events.
- NewsThe latest on the company, in one place.
And for you
- ATLAS builds your portfolioAnswer a short test and get portfolios that fit you.
- AlertsWe let you know when something changes in your stocks.
- Crisis simulatorHow your portfolio would do in a crash like 2008.
- Practice risk-free$10,000 in virtual money to invest at real prices.
- Global screenerSearch US stocks and stocks from 47 countries with filters.
Plans from €3.99 a month.
ATLAS's model gives Profound Medical a 46% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $4.89 and $6.28; in 9 out of 10, between $3.91 and $7.84. Estimated annual volatility is 75%.
Price, last 12 months (weekly close)
Key numbers
- Market cap
- $213M
- 52-week high
- $8.95
- 52-week low
- $4.80
- Revenue (12 months)
- $19.1M
- Revenue growth (YoY)
- +50.7%
- Gross margin
- 70.8%
- Operating margin
- -256.3%
- Net margin
- -264.4%
- Return on equity
- -73.5%
- Free cash flow (12 months)
- $-24.8M
- Beta
- 0.50
What this means
ATLAS does not publish a fair value for PROF right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks PROF has traded between $4.80 and $8.95. Today it is 37.1% below that high and 17% above its low.
On the business: revenue grew 50.7% year over year; net margin is 264.4%.
Its beta is 0.50: it tends to move less than the market.
About the company
Profound Medical Corp. is a commercial-stage medical device company focused on developing and marketing incision-free therapeutic systems for image-guided ablation of diseased tissue.
Want to see everything about Profound Medical?
Get started →Plans from €3.99 a month.
Comparable companies
Other companies in the same line of business:
Frequently asked questions
What does Profound Medical do?
Profound Medical Corp. is a commercial-stage medical device company focused on developing and marketing incision-free therapeutic systems for image-guided ablation of diseased tissue.
What is the chance PROF goes up next month?
46%: close to a coin flip. In half of the simulated outcomes, PROF ends the month between $4.89 and $6.28.
How big is Profound Medical and what is its P/E ratio?
Profound Medical's market capitalization is $213M. We do not show a P/E because it has no positive earnings to base one on.
How volatile is PROF?
ATLAS estimates annual volatility at 75%. In a typical month, half of the outcomes end between $4.89 and $6.28.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer